In Early Studies, Patient Clinical Outcomes Show Test Predictive Accuracy At 80%
Our evidence is growing through multiple clinical research studies with major medical institutions throughout the United States. Review Travera Clinical Study Summary
Case Studies
Case Study AT025
Lung cancer patient gets a new therapy option
Testing live cancer cells of a 77-year-old male with metastatic lung cancer reveals significant mass response to Carboplatin and Etoposide.
Case Study AT031
Testing confirms response failure to genomic biomarker-directed therapy
Rapid Therapy Guidance test confirms the suspicion that metastatic non-small cell lung cancer with confirmed MET Exon 14 skipping mutation has stopped responding to Capmatinib.
Travera’s latest Peer-reviewed Paper
on Nature’s Communications Biology
The paper describes how Travera’s technology offers a promising complement to genomics-based cancer therapy guidance by testing drug efficacy directly on a patient’s tumor cells. The combination of high-resolution measurement, broad drug and malignancy applicability, and rapid return of results offered by Travera suggests that it is well-suited to performing clinically relevant functional assessment of cancer drug response.
Read the full paper
https://www.nature.com/articles/s42003-022-04270-3
Participating institutions
The institutions involved in our clinical studies include:
Dana-Farber Cancer Institute in Boston, MA, is a world leader in adult and pediatric cancer treatment and research.
.
For over 100 years, Weill Cornell Medicine in New York City has been a community of world-class physicians, researchers and educators.
The VA Boston Medical Center is the major tertiary care center for the New England Region. It hosts a number of clinical centers of excellence.
Massachusetts General Hospital is the original and largest teaching hospital of Harvard Medical School located in the West End neighborhood of Boston, MA.
The Icahn School of Medicine at Mount Sinai in New York City is an international leader in medical and scientific training, biomedical research, and patient care.
City of Hope is a comprehensive cancer center in California. A national leader in advancing research and treatment protocols.
.